SAFE Partners with JUNO Genetics to Elevate Standards on the International Stage at ESHRE

Industry
โดย HoonVision·Read original
Summary · why it matters

Safe Fertility Group Public Company Limited, or SAFE, has joined forces with JUNO Genetics, a global partner from the United States, to participate in the 42nd ESHRE international scientific congress in London, United Kingdom, aiming to raise the standard of infertility treatment to an international level. Led by Dr. Wiwat Kwangkananurak, Chief Executive Officer, and Dr. Sujin Chanchamroen, Chief Laboratory Officer, along with a team of physicians and embryologists, this participation seeks to exchange knowledge and update the latest innovations in assisted reproductive technology. Insights from world-class experts will be applied to further develop treatment approaches and deliver the best possible outcomes for patients.

Impact on stocks 1

Health Care▲ · 1 stocks

Off-coverage companies 1

JUNO GeneticsPrivate▲ Positive
Technologyrelevance

JUNO Genetics partners with SAFE to participate in ESHRE congress, showcasing its expertise and potentially expanding its international presence.

© 2026 MarketDXNews